Efficacy and safety of a combined use of alpha1-blocker doxazosin and phosphodiesterase-5 inhibitor udenafil in patients with benign prostatic hyperplasia

Efficacy and safety of a combined use of alpha1-blocker doxazosin and phosphodiesterase-5 inhibitor udenafil in patients with benign prostatic hyperplasia

Show other versions (1)

<p align="LEFT">The paper presents the results of examination and treatment in 32 men aged 45 to 73 years with lower urinary tract symptoms caused by benign prostatic hyperplasia. The examination revealed that 53.1 % of patients reported reduced erectile function. All patients receiv...

Full description

Bibliographic Details
Main Authors: S. K. Martazinova, P. A. Scheplev
Format: Article
Language:Russian
Published: ABV-press 2014-11-01
Series:Andrologiâ i Genitalʹnaâ Hirurgiâ
Subjects:
benign prostatic hyperplasia
phosphodiesterase-5 inhibitors
ectile dysfunction
alpha1-blockers
udenafil
zidena
artezin
Online Access:http://agx.abvpress.ru/index.php/jour/article/view/48

Internet

http://agx.abvpress.ru/index.php/jour/article/view/48

Similar Items